Skip to main content
. 2022 May 30;13:817597. doi: 10.3389/fimmu.2022.817597

Figure 2.

Figure 2

S antibody levels in healthy individuals (n = 345) and individuals with clinical conditions (including Rheumatic, Renal, Obesity, Type 2 diabetes, Psoriasis and Multiple sclerosis, n = 34) after the second dose of the Sinopharm vaccine. Differences between individuals with clinical conditions were assessed by Mann Whitney test. The asterisks indicate ***p value < 0.001.